Datasets:

electricsheepafrica
/

tb-treatment-cascade

id int64	age int64	sex string	child int64	education string	urban int64	bmi float64	underweight int64	hiv_positive int64	on_art int64	cd4_count int64	diabetes int64	smoker int64	alcohol_use int64	previous_tb int64	household_tb_contact int64	mining_exposure int64	tb_type string	symptom_duration_weeks int64	cough int64	weight_loss int64	night_sweats int64	fever int64	haemoptysis int64	cavitary_disease int64	diagnostic_method string	smear_positive int64	chest_xray_done int64	rifampicin_sensitive int64	diagnosis_delay_days int64	hiv_tested_at_tb_diagnosis int64	treatment_regimen string	treatment_started int64	treatment_start_delay_days int64	dot_received int64	cotrimoxazole_prophylaxis int64	intensive_phase_completed int64	sputum_conversion_2_months int64	continuation_phase_completed int64	adherence_rate float64	side_effects int64	hepatotoxicity int64	peripheral_neuropathy int64	treatment_outcome string	died_during_treatment int64	treatment_success int64
1	39	M	0	secondary	0	12.7	1	0	0	0	0	0	1	0	0	0	pulmonary	4	1	1	0	1	0	0	clinical	1	0	1	43	1	2HRZE_4HR	1	2	1	0	1	1	1	0.8	0	0	0	cured	0	1
2	50	M	0	primary	1	21.8	0	0	0	0	0	0	0	0	0	0	pulmonary	3	1	1	1	0	0	0	clinical	1	1	1	17	1	2HRZE_4HR	1	6	1	0	1	1	1	0.94	0	0	0	cured	0	1
3	47	M	0	secondary	1	16.3	1	1	1	353	0	0	0	0	0	0	pulmonary	2	1	1	1	1	0	0	smear_microscopy	1	1	1	22	1	2HRZE_4HR	1	2	0	0	1	1	0	0.66	0	0	0	lost_to_followup	0	0
4	32	M	0	tertiary	0	13.5	1	1	1	160	0	0	0	0	0	0	pulmonary	2	1	1	1	1	1	1	smear_microscopy	1	0	1	17	1	2HRZE_4HR	1	0	0	1	1	1	1	1	0	0	0	cured	0	1
5	38	M	0	primary	1	19	0	0	0	0	0	1	0	1	0	0	pulmonary	16	1	1	0	1	1	0	smear_microscopy	0	0	1	29	0	2HRZE_4HR	1	10	1	0	0	0	0	0.9	1	0	0	failed	0	0
6	37	F	0	primary	1	20.3	0	0	0	0	0	1	0	0	0	0	pulmonary	2	1	1	1	1	0	1	smear_microscopy	0	0	1	39	1	2HRZE_4HR	1	2	1	0	1	0	1	0.84	0	0	0	completed	0	1
7	30	F	0	secondary	1	17.8	1	1	1	330	0	0	0	1	0	0	pulmonary	4	1	1	0	1	0	0	smear_microscopy	0	1	1	8	1	2HRZE_4HR	1	3	1	1	1	0	1	0.79	0	0	0	completed	0	1
8	10	M	1	primary	1	15.7	1	0	0	0	0	0	0	1	1	0	pulmonary	4	1	1	0	1	0	1	smear_microscopy	1	1	1	7	1	2HRZE_4HR	1	3	1	0	1	0	1	0.89	1	0	0	cured	0	1
9	24	M	0	primary	1	23.7	0	1	0	10	0	0	0	0	0	0	pulmonary	8	1	1	1	0	0	0	clinical	1	1	1	19	1	2HRZE_4HR	1	1	1	1	1	1	1	1	0	0	0	cured	0	1
10	41	F	0	secondary	0	18.5	0	0	0	0	0	0	0	0	0	0	pulmonary	8	1	0	1	0	1	0	clinical	0	0	1	27	0	2HRZE_4HR	1	13	1	0	1	0	1	0.99	0	0	0	completed	0	1
11	36	F	0	primary	0	17.4	1	1	1	471	0	0	0	0	0	0	extrapulmonary	17	1	1	1	1	0	0	clinical	0	1	1	100	1	2HRZE_4HR	1	1	1	0	1	0	1	0.85	0	0	0	completed	0	1
12	42	F	0	secondary	1	25.1	0	0	0	0	1	0	0	0	0	0	pulmonary	2	0	1	0	0	0	0	smear_microscopy	0	1	1	60	1	2HRZE_4HR	1	0	1	0	1	0	1	0.95	0	0	0	died	1	0
13	33	M	0	secondary	0	14.3	1	0	0	0	1	0	0	0	0	0	pulmonary	6	1	1	0	0	0	1	clinical	1	1	1	12	0	2HRZE_4HR	1	0	1	0	1	0	1	0.96	1	0	0	cured	0	1
14	32	M	0	none	0	18.3	1	0	0	0	0	0	0	0	0	0	pulmonary	2	1	1	1	1	0	0	smear_microscopy	1	1	1	36	1	2HRZE_4HR	1	1	1	0	1	1	1	0.8	0	0	0	cured	0	1
15	30	M	0	primary	0	28.6	0	0	0	0	0	0	0	0	0	0	pulmonary	9	1	1	1	0	1	1	smear_microscopy	1	0	1	25	1	2HRZE_4HR	1	20	1	0	1	1	1	0.49	0	0	0	relapsed	0	0
16	41	F	0	primary	0	19.2	0	1	1	350	0	0	0	0	0	0	extrapulmonary	3	0	1	1	0	0	0	clinical	0	0	1	53	1	2HRZE_4HR	1	6	1	1	1	0	1	0.99	0	0	0	completed	0	1
17	23	F	0	secondary	0	18.9	0	1	1	356	0	0	0	0	0	0	extrapulmonary	19	0	1	0	1	0	0	clinical	0	0	1	20	1	2HRZE_4HR	1	12	1	1	1	0	1	0.83	0	0	0	completed	0	1
18	14	M	1	primary	0	20.2	0	0	0	0	0	0	0	0	0	0	extrapulmonary	13	0	0	0	1	0	0	clinical	0	0	1	28	1	2HRZE_4HR	1	2	0	0	1	0	1	0.5	1	0	0	failed	0	0
19	42	F	0	none	0	17.3	1	0	0	0	0	1	0	1	1	0	pulmonary	5	1	0	0	0	1	1	clinical	0	1	1	38	1	2HRZE_4HR	1	13	0	0	1	0	1	0.41	0	0	0	failed	0	0
20	30	M	0	secondary	1	21.5	0	1	1	354	0	0	0	0	0	0	pulmonary	22	1	0	1	1	0	1	smear_microscopy	1	1	1	72	1	2HRZE_4HR	1	7	0	1	1	0	1	0.51	0	0	0	cured	0	1
21	45	F	0	primary	1	22.4	0	1	0	307	0	0	0	0	0	0	extrapulmonary	4	0	0	0	1	0	0	clinical	0	1	1	10	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
22	39	M	0	none	0	16.6	1	1	1	105	0	0	0	1	1	0	pulmonary	12	1	1	1	1	1	1	clinical	1	0	1	28	1	2HRZE_4HR	1	9	0	1	1	1	1	0.59	1	0	0	cured	0	1
23	41	M	0	none	1	20.5	0	1	1	371	0	0	0	0	0	0	pulmonary	3	1	1	0	0	0	0	smear_microscopy	0	0	1	26	1	2HRZE_4HR	1	12	1	1	1	0	1	0.93	1	0	1	completed	0	1
24	58	F	0	primary	0	24.2	0	1	1	85	0	0	0	1	1	0	extrapulmonary	3	1	0	0	1	0	0	clinical	0	0	1	12	1	2HRZE_4HR	1	0	1	0	1	0	1	0.98	0	0	0	completed	0	1
25	19	M	0	secondary	0	23.3	0	0	0	0	0	0	0	0	1	0	pulmonary	14	1	0	1	0	1	0	smear_microscopy	1	0	1	35	1	2HRZE_4HR	1	9	0	0	1	1	1	0.38	0	0	0	cured	0	1
26	29	F	0	secondary	1	24.5	0	0	0	0	0	1	0	0	0	0	extrapulmonary	8	0	1	0	1	0	0	clinical	0	1	1	111	1	2HRZE_4HR	1	0	1	0	1	0	1	0.9	0	0	0	failed	0	0
27	34	F	0	primary	1	14.8	1	0	0	0	0	0	1	0	0	0	pulmonary	4	1	1	1	0	0	0	clinical	0	0	1	10	1	2HRZE_4HR	1	1	1	0	1	0	1	0.78	1	0	1	failed	0	0
28	41	M	0	primary	0	19	0	1	0	559	0	1	0	0	1	0	pulmonary	3	1	0	0	1	0	1	smear_microscopy	1	0	1	83	1	2HRZE_4HR	1	1	1	1	1	1	1	0.9	0	0	0	failed	0	0
29	18	M	0	none	1	20.2	0	1	1	430	0	0	0	0	0	0	pulmonary	9	1	0	1	1	0	0	clinical	0	0	1	28	0	2HRZE_4HR	1	7	1	0	1	0	1	0.96	1	0	0	completed	0	1
30	21	F	0	primary	0	14.5	1	0	0	0	0	0	0	0	0	0	pulmonary	2	1	0	0	0	0	0	smear_microscopy	0	0	1	48	1	2HRZE_4HR	1	0	1	0	1	0	1	0.84	0	0	0	completed	0	1
31	35	M	0	secondary	0	22.1	0	1	1	466	0	0	0	0	1	0	pulmonary	7	1	0	1	1	0	0	clinical	1	0	1	37	0	2HRZE_4HR	1	4	1	1	1	1	1	0.95	0	0	0	cured	0	1
32	44	F	0	primary	1	17.6	1	0	0	0	0	0	0	0	0	0	pulmonary	6	1	1	1	1	0	0	smear_microscopy	0	0	1	32	1	2HRZE_4HR	1	11	0	0	1	0	1	0.57	0	0	0	failed	0	0
33	53	F	0	tertiary	0	20.4	0	1	1	259	0	0	1	0	1	0	pulmonary	4	1	1	0	0	0	0	smear_microscopy	0	0	1	18	1	2HRZE_4HR	1	0	1	1	1	0	1	0.75	0	0	0	completed	0	1
34	31	M	0	secondary	1	19.8	0	1	1	302	0	1	1	0	0	1	pulmonary	12	1	1	0	0	0	0	smear_microscopy	1	0	1	20	1	2HRZE_4HR	1	7	1	1	1	1	1	0.93	1	0	1	failed	0	0
35	38	F	0	primary	1	19.5	0	0	0	0	0	0	0	0	0	0	pulmonary	7	1	0	0	1	1	0	smear_microscopy	1	1	1	23	1	2HRZE_4HR	1	3	1	0	1	1	1	0.75	1	1	0	relapsed	0	0
36	33	M	0	primary	0	22.1	0	1	1	65	0	0	1	0	0	0	pulmonary	8	1	1	1	1	0	0	smear_microscopy	0	0	1	9	1	2HRZE_4HR	1	8	1	0	1	0	1	0.9	0	0	0	completed	0	1
37	45	F	0	secondary	0	17.6	1	0	0	0	0	0	0	0	0	0	pulmonary	2	1	1	1	0	0	0	smear_microscopy	1	0	1	25	0	2HRZE_4HR	1	1	1	0	1	1	1	0.76	0	0	0	cured	0	1
38	59	M	0	secondary	1	22.3	0	0	0	0	0	0	0	0	0	0	pulmonary	13	1	0	0	1	1	0	smear_microscopy	1	0	1	74	1	2HRZE_4HR	1	0	0	0	1	0	1	0.8	0	0	0	cured	0	1
39	5	M	1	tertiary	0	17.2	1	1	1	258	0	0	0	0	1	0	pulmonary	9	0	1	1	1	1	0	clinical	1	0	1	18	1	2HRZ_4HR	1	5	1	1	1	1	1	0.88	0	0	0	cured	0	1
40	33	M	0	primary	1	22.6	0	0	0	0	0	0	1	0	0	0	pulmonary	4	1	1	0	0	1	0	smear_microscopy	0	1	1	88	1	2HRZE_4HR	1	0	0	0	1	0	1	0.64	0	0	0	completed	0	1
41	47	F	0	primary	1	20.8	0	0	0	0	0	0	0	0	0	0	pulmonary	16	1	0	1	1	0	0	clinical	1	1	1	63	1	2HRZE_4HR	1	1	1	0	1	1	0	1	1	0	0	lost_to_followup	0	0
42	43	M	0	tertiary	0	23.6	0	1	1	176	0	0	0	0	0	0	pulmonary	6	1	0	1	1	0	0	clinical	1	0	1	41	1	2HRZE_4HR	1	8	1	1	1	1	1	0.82	1	1	0	cured	0	1
43	28	F	0	primary	0	17.2	1	1	1	465	0	0	1	0	0	0	extrapulmonary	12	1	0	0	0	0	0	clinical	0	0	1	33	0	2HRZE_4HR	1	5	1	1	0	0	0	0.75	0	0	0	failed	0	0
44	16	M	0	primary	0	19.9	0	1	1	10	0	0	0	1	0	0	pulmonary	2	1	0	0	0	0	0	smear_microscopy	1	1	1	20	1	2HRZE_4HR	1	5	1	1	1	1	1	0.71	0	0	0	cured	0	1
45	39	M	0	primary	1	19.3	0	1	1	260	0	0	0	0	0	0	pulmonary	5	1	0	0	0	0	0	smear_microscopy	1	1	1	99	1	2HRZE_4HR	1	4	1	0	1	1	1	0.65	0	0	0	relapsed	0	0
46	38	M	0	secondary	0	13.3	1	0	0	0	0	0	1	1	0	0	pulmonary	7	1	1	0	1	0	1	clinical	0	1	1	14	0	2HRZE_4HR	1	2	1	0	1	0	1	0.89	0	0	0	died	1	0
47	49	F	0	none	1	19	0	0	0	0	0	0	0	0	1	0	pulmonary	5	1	0	0	0	0	0	smear_microscopy	0	1	1	38	1	2HRZE_4HR	1	7	1	0	1	0	1	0.91	0	0	0	relapsed	0	0
48	31	M	0	none	0	21.4	0	1	0	298	1	0	0	0	1	0	extrapulmonary	6	1	1	0	1	0	0	clinical	0	0	1	80	1	2HRZE_4HR	1	5	0	1	1	0	1	0.52	0	0	0	completed	0	1
49	44	M	0	primary	0	23.6	0	0	0	0	0	0	0	0	0	0	pulmonary	6	0	0	0	1	0	0	clinical	1	0	1	180	1	2HRZE_4HR	1	4	0	0	1	1	1	0.51	0	0	0	cured	0	1
50	31	M	0	secondary	0	23.8	0	1	1	169	1	0	0	1	0	0	extrapulmonary	11	0	1	1	0	0	0	clinical	0	1	1	17	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
51	28	F	0	secondary	0	26.2	0	0	0	0	0	0	0	0	0	0	pulmonary	8	1	0	0	0	0	1	smear_microscopy	1	1	1	8	0	2HRZE_4HR	1	0	0	0	1	1	1	0.69	0	0	0	cured	0	1
52	27	M	0	primary	1	16.6	1	1	1	471	0	0	0	0	0	0	pulmonary	9	1	1	0	1	0	1	smear_microscopy	0	1	1	48	1	2HRZE_4HR	1	17	1	1	1	0	1	0.7	1	0	0	completed	0	1
53	28	F	0	primary	0	23.4	0	0	0	0	0	0	0	0	0	0	pulmonary	5	1	0	1	1	0	0	smear_microscopy	1	1	1	7	1	2HRZE_4HR	1	3	1	0	1	1	0	0.8	0	0	0	lost_to_followup	0	0
54	30	M	0	secondary	1	21.2	0	0	0	0	0	0	0	0	0	0	pulmonary	14	0	1	0	0	0	1	smear_microscopy	0	1	1	12	0	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
55	31	F	0	primary	1	21	0	0	0	0	0	0	0	0	0	0	pulmonary	4	1	0	1	1	0	0	smear_microscopy	1	1	1	26	1	2HRZE_4HR	1	0	1	0	1	0	1	0.68	0	0	0	cured	0	1
56	49	F	0	none	1	21.9	0	0	0	0	0	0	0	0	0	0	extrapulmonary	9	0	1	1	1	0	0	clinical	0	1	1	11	1	2HRZE_4HR	1	1	1	0	1	0	1	0.66	0	0	0	completed	0	1
57	19	M	0	none	1	14.1	1	0	0	0	0	0	0	0	1	0	pulmonary	12	1	0	0	0	0	0	smear_microscopy	0	1	1	148	1	2HRZE_4HR	1	1	0	0	1	0	1	0.47	0	0	0	completed	0	1
58	26	F	0	primary	1	13.5	1	0	0	0	0	0	0	0	0	0	pulmonary	13	1	1	0	1	0	0	smear_microscopy	1	1	1	30	1	2HRZE_4HR	1	7	1	0	1	0	1	0.73	0	0	0	relapsed	0	0
59	37	M	0	none	1	16.9	1	1	1	236	0	0	0	0	1	0	pulmonary	10	1	1	1	1	0	0	smear_microscopy	1	1	1	10	1	2HRZE_4HR	1	5	1	0	0	0	0	0.88	0	0	0	lost_to_followup	0	0
60	39	F	0	tertiary	0	17.9	1	0	0	0	0	1	0	0	1	0	pulmonary	4	1	1	0	1	1	1	clinical	1	0	1	17	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
61	35	F	0	primary	0	14.8	1	0	0	0	0	0	0	0	0	0	pulmonary	7	1	1	1	0	0	0	smear_microscopy	1	0	1	19	1	2HRZE_4HR	1	9	1	0	1	0	1	0.94	0	0	0	cured	0	1
62	40	F	0	tertiary	0	17.4	1	0	0	0	0	0	1	0	0	0	pulmonary	12	1	0	1	1	1	1	smear_microscopy	1	1	1	12	1	2HRZE_4HR	1	4	1	0	1	1	1	0.87	0	0	0	failed	0	0
63	26	F	0	secondary	0	20	0	0	0	0	0	0	0	0	0	0	pulmonary	2	1	1	0	0	0	0	smear_microscopy	1	0	1	8	1	2HRZE_4HR	1	4	1	0	1	1	0	0.94	0	0	0	lost_to_followup	0	0
64	23	M	0	primary	1	27.2	0	0	0	0	0	0	0	0	0	0	extrapulmonary	21	1	1	1	0	0	0	clinical	0	1	1	17	0	2HRZE_4HR	1	2	0	0	1	0	1	0.81	1	0	0	completed	0	1
65	19	F	0	none	1	16.7	1	0	0	0	0	0	1	1	0	0	pulmonary	7	1	0	1	1	0	0	smear_microscopy	1	1	1	54	1	2HRZE_4HR	1	0	0	0	1	1	1	0.95	0	0	0	cured	0	1
66	10	F	1	none	1	26.5	0	0	0	0	0	0	0	0	1	0	pulmonary	4	1	1	1	0	0	0	smear_microscopy	0	1	1	9	0	2HRZE_4HR	1	20	0	0	1	0	1	0.79	0	0	0	completed	0	1
67	22	M	0	secondary	0	17.2	1	0	0	0	0	0	0	0	0	0	pulmonary	31	1	0	0	1	0	0	clinical	1	1	1	103	1	2HRZE_4HR	1	3	0	0	1	1	1	0.76	1	0	1	cured	0	1
68	20	F	0	primary	0	23.1	0	1	1	287	0	0	0	0	1	0	pulmonary	5	1	1	1	0	0	0	smear_microscopy	1	0	1	7	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
69	17	M	0	secondary	0	23.8	0	0	0	0	0	0	1	0	0	0	pulmonary	3	1	1	1	0	0	0	smear_microscopy	0	0	1	10	1	2HRZE_4HR	1	9	1	0	1	0	1	0.79	0	0	0	completed	0	1
70	38	F	0	none	0	19.7	0	0	0	0	0	0	0	0	0	0	pulmonary	4	1	1	1	1	0	0	smear_microscopy	0	0	1	40	1	2HRZE_4HR	1	0	0	0	0	0	0	0.8	0	0	0	lost_to_followup	0	0
71	32	M	0	none	0	16.1	1	1	1	475	0	0	0	0	0	0	pulmonary	31	1	1	0	0	0	0	smear_microscopy	1	1	1	14	1	2HRZE_4HR	1	5	1	1	1	1	0	0.56	1	0	0	lost_to_followup	0	0
72	31	F	0	secondary	1	21.9	0	0	0	0	0	0	0	0	0	0	pulmonary	9	1	1	0	1	0	0	smear_microscopy	0	0	1	16	1	2HRZE_4HR	1	8	1	0	1	0	1	0.81	0	0	0	completed	0	1
73	57	M	0	secondary	0	24.2	0	0	0	0	0	0	0	0	0	0	pulmonary	3	1	1	0	1	0	1	smear_microscopy	0	0	1	40	1	2HRZE_4HR	1	4	0	0	1	0	1	0.68	0	0	0	completed	0	1
74	45	F	0	primary	1	17.9	1	0	0	0	0	0	1	0	0	0	pulmonary	8	1	1	1	1	0	0	smear_microscopy	1	1	1	21	1	2HRZE_4HR	1	1	1	0	1	1	0	0.92	0	0	0	lost_to_followup	0	0
75	6	F	1	secondary	1	25.9	0	0	0	0	0	0	0	0	0	0	pulmonary	4	1	1	1	1	0	0	clinical	1	1	1	29	1	2HRZ_4HR	1	4	0	0	1	1	1	0.73	0	0	0	cured	0	1
76	47	F	0	primary	0	18.4	1	1	1	282	0	1	0	0	0	0	pulmonary	7	1	0	1	0	1	0	smear_microscopy	1	1	1	35	1	2HRZE_4HR	1	2	1	0	1	1	1	0.75	0	0	0	cured	0	1
77	43	F	0	primary	0	22.3	0	0	0	0	1	1	0	0	0	0	pulmonary	14	1	1	0	1	0	1	clinical	0	0	1	21	0	2HRZE_4HR	1	2	1	0	1	0	1	0.63	0	0	0	completed	0	1
78	55	F	0	secondary	0	16.6	1	0	0	0	0	0	1	0	0	0	pulmonary	6	1	0	0	0	0	0	clinical	1	0	1	40	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
79	39	M	0	none	1	24.4	0	0	0	0	0	0	0	0	0	0	pulmonary	6	1	1	1	1	0	0	smear_microscopy	0	0	1	46	1	2HRZE_4HR	1	1	1	0	1	0	1	1	0	0	0	completed	0	1
80	21	M	0	secondary	0	23.7	0	1	1	349	0	0	0	0	0	0	pulmonary	13	1	1	0	0	0	1	smear_microscopy	0	1	1	27	0	2HRZE_4HR	1	4	1	0	1	0	1	0.81	0	0	0	failed	0	0
81	31	M	0	primary	0	24.5	0	1	1	214	0	0	0	1	0	0	pulmonary	8	1	1	1	1	1	1	clinical	0	1	1	66	1	2HRZE_4HR	1	3	1	1	1	0	0	0.95	0	0	0	lost_to_followup	0	0
82	51	M	0	secondary	0	12	1	1	1	242	1	0	0	0	0	0	pulmonary	2	1	1	1	1	0	0	smear_microscopy	0	0	1	21	1	2HRZE_4HR	1	6	1	1	1	0	1	1	0	0	0	completed	0	1
83	23	M	0	primary	0	23.2	0	1	1	362	0	1	1	0	0	0	pulmonary	19	1	1	1	0	0	0	smear_microscopy	1	0	1	62	1	2HRZE_4HR	1	2	0	1	1	1	1	1	1	0	0	cured	0	1
84	25	F	0	primary	1	19.8	0	0	0	0	0	0	0	0	0	0	pulmonary	15	1	1	0	1	0	0	smear_microscopy	1	1	1	7	1	2HRZE_4HR	1	23	1	0	1	1	1	0.68	1	0	0	died	1	0
85	27	M	0	primary	1	22.5	0	1	1	351	0	1	1	0	0	0	pulmonary	14	1	0	1	0	0	0	clinical	1	0	1	30	1	2HRZE_4HR	0	0	0	0	0	0	0	0	0	0	0	not_evaluated	0	0
86	43	F	0	secondary	0	17.5	1	0	0	0	0	0	1	0	0	0	pulmonary	11	1	1	0	1	0	0	smear_microscopy	1	0	1	33	1	2HRZE_4HR	1	4	1	0	1	1	1	0.62	1	0	0	failed	0	0
87	39	M	0	secondary	0	19.5	0	1	1	271	0	0	0	0	1	0	extrapulmonary	5	0	1	0	1	0	0	clinical	0	0	1	17	1	2HRZE_4HR	1	1	1	1	1	0	0	0.85	0	0	0	lost_to_followup	0	0
88	28	F	0	secondary	0	20.8	0	1	1	524	0	0	1	0	1	0	pulmonary	26	1	1	1	1	0	0	smear_microscopy	0	1	1	84	1	2HRZE_4HR	1	5	1	0	1	0	1	1	0	0	0	completed	0	1
89	38	F	0	primary	0	23.6	0	1	1	205	0	0	0	0	1	0	pulmonary	19	1	1	0	1	0	1	clinical	0	0	1	7	1	2HRZE_4HR	1	7	0	0	1	0	1	0.54	0	0	0	completed	0	1
90	67	F	0	none	0	20.4	0	0	0	0	0	0	1	0	0	0	pulmonary	6	1	0	1	1	0	1	clinical	1	1	1	40	1	2HRZE_4HR	1	19	0	0	1	1	1	0.67	1	1	0	relapsed	0	0
91	27	M	0	primary	0	12.3	1	0	0	0	0	0	1	1	0	0	pulmonary	3	0	1	0	1	0	1	clinical	1	1	1	37	1	2HRZE_4HR	1	2	1	0	1	1	1	0.91	0	0	0	cured	0	1
92	48	M	0	primary	1	17.9	1	0	0	0	0	0	1	1	0	0	pulmonary	2	1	1	1	1	0	1	clinical	0	0	1	29	0	2HRZE_4HR	1	0	1	0	1	0	1	0.79	0	0	0	died	1	0
93	28	M	0	tertiary	0	20	0	0	0	0	0	0	0	1	1	0	pulmonary	13	1	0	0	0	1	0	smear_microscopy	1	0	1	92	1	2HRZE_4HR	1	1	1	0	1	1	1	0.88	0	0	0	died	1	0
94	23	F	0	secondary	1	21.9	0	1	1	333	0	0	0	0	0	0	extrapulmonary	5	1	1	1	1	0	0	clinical	0	1	1	31	1	2HRZE_4HR	1	1	0	1	1	0	1	0.65	0	0	0	relapsed	0	0
95	38	F	0	secondary	1	19	0	0	0	0	0	1	0	1	1	0	pulmonary	11	1	1	1	0	0	0	smear_microscopy	1	1	1	36	1	2HRZE_4HR	1	0	0	0	1	1	1	0.75	0	0	0	cured	0	1
96	42	M	0	none	0	17	1	0	0	0	0	0	1	0	0	0	extrapulmonary	4	0	0	0	0	0	0	clinical	0	0	1	18	1	2HRZE_4HR	1	7	1	0	1	0	1	0.78	0	0	0	completed	0	1
97	20	M	0	primary	0	23.7	0	0	0	0	0	0	0	0	0	0	pulmonary	24	1	1	0	0	1	1	smear_microscopy	0	1	1	97	0	2HRZE_4HR	1	8	1	0	1	0	1	0.98	1	0	1	completed	0	1
98	23	F	0	secondary	1	23.5	0	0	0	0	0	0	0	0	1	0	pulmonary	6	1	1	0	1	0	0	clinical	1	1	1	18	1	2HRZE_4HR	1	3	0	0	1	1	1	0.56	0	0	0	cured	0	1
99	29	M	0	secondary	0	24.1	0	1	1	46	0	0	0	0	0	0	pulmonary	48	1	1	1	1	1	0	smear_microscopy	0	1	1	99	0	2HRZE_4HR	1	1	1	1	0	0	0	0.93	0	0	0	lost_to_followup	0	0
100	47	M	0	secondary	0	22.2	0	1	1	274	0	0	0	0	0	0	pulmonary	2	1	1	0	1	0	1	smear_microscopy	1	0	1	102	1	2HRZE_4HR	1	11	1	1	1	1	1	0.74	0	0	0	relapsed	0	0

End of preview. Expand in Data Studio

Drug-Sensitive Tuberculosis Treatment Cascade Dataset

Abstract

This dataset provides 30,000 simulated DS-TB patient records (10,000 per scenario) from sub-Saharan Africa. Each record contains 45+ variables including demographics, TB-HIV coinfection, diagnosis method, treatment regimen (2HRZE/4HR), adherence, DOT, side effects, and WHO-standard treatment outcomes. Three settings: urban DOTS centre (64% success), district hospital (56%), and rural health post (41%).

1. Introduction

TB caused 10.8 million new cases and 1.25 million deaths globally in 2023, with SSA bearing a disproportionate burden (WHO 2024). Standard DS-TB treatment is 2HRZE/4HR (6 months). Treatment success rates in SSA range from 65-88%, with LTFU and TB-HIV coinfection as major challenges. GeneXpert rollout has improved diagnosis but treatment gaps persist. WHO targets ≥85% treatment success.

This dataset is entirely simulated. It must not be used for clinical decision-making.

2. Methodology

2.1 Parameterization

Parameter	Value	Source
Global TB incidence (2023)	10.8M	WHO 2024
TB deaths (2023)	1.25M	WHO 2024
TB-HIV coinfection SSA	~35%	WHO 2024
Treatment success target	≥85%	WHO
LTFU rate	8-25%	ScienceDirect 2025
Treatment mortality	4-6%	WHO 2024

2.2 Scenario Design

Scenario	GeneXpert	DOT	ART	Success
Urban DOTS	Yes	Yes	Integrated	64%
District hospital	No	Yes	Integrated	56%
Rural health post	No	No	No	41%

3. Schema

Column	Type	Description
id	int	Unique identifier
age	int	Patient age
sex	categorical	M / F
hiv_positive	binary	HIV coinfection
on_art	binary	On ART
cd4_count	int	CD4 count (HIV+)
tb_type	categorical	pulmonary / extrapulmonary
diagnostic_method	categorical	genexpert / smear_microscopy / clinical
smear_positive	binary	Smear positive
treatment_regimen	categorical	2HRZE_4HR / 2HRZ_4HR
treatment_started	binary	Treatment initiated
dot_received	binary	DOT received
intensive_phase_completed	binary	Intensive phase done
sputum_conversion_2_months	binary	Smear conversion
continuation_phase_completed	binary	Continuation phase done
adherence_rate	float	Treatment adherence
treatment_outcome	categorical	cured / completed / failed / lost_to_followup / died / relapsed
treatment_success	binary	Cured or completed
died_during_treatment	binary	Died

4. Validation

Validation Report

Key validation checks:

Treatment success gradient: 64% → 56% → 41% ✓
TB-HIV coinfection: ~35% ✓
LTFU gradient: 10% → 15% → 22% ✓
Cascade drop-off at each stage ✓
HIV worsens outcomes ✓
DOT improves adherence ✓

5. Usage

from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/tb-treatment-cascade", "district_hospital")
df = dataset["train"].to_pandas()

6. Limitations

Simulated: Not from real TB registries.
No molecular data: No whole-genome sequencing.
Simplified: No detailed pharmacokinetics.
No contact tracing: No household transmission data.
DS-TB only: DR-TB covered in separate dataset.

7. References

WHO (2024). Global TB Report.
Frontiers (2025). TB burden in 22 SSA countries.
WHO (2022). DS-TB treatment guidelines.
PubMed (2022). GeneXpert rollout DRC, Nigeria, SA.
ScienceDirect (2025). Multi-month dispensing TB meds SSA.
PubMed (2024). Subclinical TB linkage to care.

Citation

@dataset{esa_tb_cascade_2025,
  title={Drug-Sensitive TB Treatment Cascade Dataset},
  author={Electric Sheep Africa},
  year={2025},
  publisher={Hugging Face},
  url={https://huggingface.co/datasets/electricsheepafrica/tb-treatment-cascade}
}

License

CC-BY-4.0

Downloads last month: 24